search

Active clinical trials for "Eye Diseases"

Results 471-480 of 634

Corneal Thickness Changes in Patient Undergoing Dry Eye Managment

Dry Eye Disease

The purpose of this research is to the determine effect of dry eye and to compare the effect of artificial tears on central and peripheral corneal thickness.

Unknown status11 enrollment criteria

Supramaximal Rectus Recession for Strabismus in Grave's Ophthalmopathy

StrabismusMechanical1 more

The purpose of this study is to evaluate supramaximal rectus recession for strabismus in Grave's Ophthalmopathy

Unknown status7 enrollment criteria

A Prospective, Randomized Trial of Intravenous Pulse Versus Sequential Steroid Therapy for Patients...

Graves' Ophthalmopathy

This study was designed to compare the efficacy and safety of 4.5g iv MP administered in 12 weeks and 4 weeks.

Unknown status11 enrollment criteria

The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients....

Thyroid Eye DiseaseOcular Hypertension1 more

The purpose of this study is to evaluate the potential secondary beneficial effect of prostaglandin analogues (PA) treatment in thyroid eye disease (TED) patients. This study aims to determine if PA would change the course of the orbitopathy in TED patients by altering the progression of the common features of TED, including fatty hypertrophy, proptosis, eyelid retraction and optic nerve compression. The eyes with thyroid eye disease and elevated intraocular pressure will be randomised to the PA treatment and the other eye will serve as a control eye and will be treated with Timolol.

Withdrawn12 enrollment criteria

Fingerprick Autologous Blood (FAB) in Severe Dry Eye Disease (DED)

Dry Eye Syndromes

Dry eye disease (DED) is an umbrella term encompassing a range of diseases estimated to affect 14% of all adults aged 48 to 91. If left untreated, DED can lead to severe reduction in the quality of life of the sufferer. It can also cause loss of vision, pain in response to light, painful recurring stabbing sensations, and the feeling of grit in the affected eye(s). No curative agents for DED exist. Available conventional treatment options for DED such as artificial tears often only alleviate symptoms, have limited effectiveness, and in most cases patients may fail to respond; although the exact rate of treatment failure is unavailable in the published literature. Crudely, human tears with its vast constituents is essentially filtered blood and as such is an obvious source for a "tear mimic" containing the substances of tears. Blood, and several blood derived products, including autologous serum, have been studied as tear substitute candidates. This study proposes to test the use of finger prick autologous blood (FAB) technique in which whole blood is applied to the eye from a cleaned finger.

Unknown status14 enrollment criteria

Comparison of Efficacy and Safety of Mitomycin and Aflibercept Used to Support Primary Trabeculectomy....

Eye DiseasesOptic Nerve Damage1 more

Comparison of efficacy and safety of Mitomycin and Aflibercept used to support primary trabeculectomy - a prospective, randomized trial in patients with open-angle glaucoma undergoing surgery.

Unknown status15 enrollment criteria

Goblet Cell Degranulation Produced by Intranasal Tear Neurostimulator (ITN) in Dry Eye Disease

Dry Eye Syndromes

The purpose of this study is to evaluate goblet cell degranulation following acute use of the Intranasal Tear Neurostimulator in participants with dry eye.

Terminated9 enrollment criteria

Eyelash Prostheses Compared to 5.0% Lifitegrast BID for Dry Eye Disease.

Dry Eye

This is a single-center, randomized, controlled trial to evaluate the safety and efficacy of eyelash prostheses versus 5.0% Lifitegrast BID, in 40 patients (20 randomized to each of two arms of the study) evaluated at 3 weeks and 5 weeks, respectively, after initiation of treatment.

Unknown status21 enrollment criteria

Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of GLH8NDE in Patients With Dry Eye Disease...

Dry Eye Syndromes

This study is a randomized, double-blind, placebo-controlled phase 2 clinical trial to evaluate the efficacy and safety of GLH8NDE in patients with Dry Eye Disease.

Unknown status37 enrollment criteria

Epi-on PiXL for the Treatment of Progressive Keratoconus.

KeratoconusCorneal Crosslinking4 more

The purpose of this study is to evaluate the efficacy, safety and postoperative ocular discomfort by individually customized Photorefractive intrastromal crosslinking (PiXL) without epithelium debridement in high oxygen environment (Epi-on) for progressive Keratoconus.

Unknown status13 enrollment criteria
1...474849...64

Need Help? Contact our team!


We'll reach out to this number within 24 hrs